https://www.selleckchem.com/pr....oducts/zotatifin.htm
Introduction Intermittent claudication (IC) and chronic limb-threatening ischemia (CLTI) are both associated with a decreased health status (HS), and possibly quality of life (QOL). A better understanding of the differences in QOL between patients with IC and CLTI could be of additional value in shared decision making. The aim of this study was to compare the QOL at baseline between patients with IC and patients with CLTI. Material and methods The study population was based on two study cohorts, one cohort consisted of patients with I